Vanderbilt University Medical Center has received an 18-month, $6.9 million award to set up a Clinical Data Research Network (CDRN) that can reach millions of patients and speed the translation of research findings into clinical practice.

Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery.

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

Tina Hartert, M.D., MPH, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine, has been named assistant vice chancellor for Translational Science.

Alvin Powers, M.D., professor of Medicine and Molecular Physiology and Biophysics, has been named to the American Diabetes Association Board of Directors.

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).